Analysts Offer Insights on Healthcare Companies: SCYNEXIS (SCYX) and Abivax SA Sponsored ADR (ABVX)
at www.tipranks.com (Thu, 2-Jul 4:30 AM)
Scynexis: Buy Rating Reiterated as Rare Disease Pipeline Advances; $32 Price Target Maintained
at www.tipranks.com (Wed, 1-Jul 3:25 PM)
